Chapter 50 – The Clayton Act, the Robinson–Patman Act, and Antitrust Exemptions and Immunities
50-4
© 2016 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in any
manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part.
b. The Warren Court (the Supreme Court from the mid-1950s to 1969) plainly agreed
with the anticoncentration thrust of Section 7, and sometimes struck down mergers
whose potential anticompetitive effect was dubious at best. For an example, see
United States v. Von’s Grocery Co., 384 U.S. 270 (1966), a case that may represent
the high-water mark of Section 7 enforcement.
c. Although the Burger Court (the Court from 1969 to 1986) did not expressly overrule
any of the Warren Court’s major merger decisions, United States v. General
Dynamics, 415 U.S. 486 (1974), signaled an intent to insist on more in the way of
plaintiff-competitor had failed to demonstrate that the proposed merger posed a threat
of antitrust injury, and that losses or damage flowing from increased competition do
not constitute such an injury. The dissenters, Justices Stevens and White, argued that
the practical effect of the Court’s decision was to prevent private parties from
the merger itself.”
d. Discuss the approach to horizontal mergers adopted by the federal government’s
merger guidelines.
1) Note the obvious need to examine the degree of concentration in the existing
market and the increase in concentration that would result from the proposed
merger.
2) Discuss the nonmarket share factors that the Justice Department and the FTC will
consider in deciding whether to challenge a merger: the existence of barriers to the
ProMedica Health System, Inc. v. FTC (p. 1377): The U.S. Court of Appeals
upholds the FTC’s determination that a merger between ProMedica and one of its
services (except for OB) and secondary inpatient services, and (2) OB services.